Cencora Inc
COR351.559USD
+5.559+1.61%
Market hours （ET）Quotes delayed by 15 min
68.18BMarket Cap
43.84P/E TTM
More Details of Cencora Inc Company
Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
Cencora Inc Info
Ticker SymbolCOR
Company nameCencora Inc
IPO dateMay 28, 1996
CEOMauch (Robert P)
Number of employees51000
Security typeOrdinary Share
Fiscal year-endMay 28
Address1 West First Avenue
CityCONSHOHOCKEN
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code19428
Phone16107277000
Websitehttps://www.cencora.com/
Ticker SymbolCOR
IPO dateMay 28, 1996
CEOMauch (Robert P)
Company Executives of Cencora Inc
Name
Name/Position
Position
Shareholding
Change
Ms. Elizabeth S. Campbell
Ms. Elizabeth S. Campbell
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
27.24K
+112.43%
Ms. Silvana Battaglia
Ms. Silvana Battaglia
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
20.47K
+80.39%
Mr. Lon R. Greenberg
Mr. Lon R. Greenberg
Independent Director
Independent Director
19.11K
-13.57%
Mr. Dennis M. Nally
Mr. Dennis M. Nally
Independent Director
Independent Director
12.63K
+0.83%
Mr. Pawan Verma
Mr. Pawan Verma
Executive Vice President, Chief Data and Information Officer
Executive Vice President, Chief Data and Information Officer
5.15K
+23.04%
Mr. Werner Baumann
Mr. Werner Baumann
Independent Director
Independent Director
3.13K
+3.57%
Dr. Lorence H. Kim, M.D.
Dr. Lorence H. Kim, M.D.
Independent Director
Independent Director
957.00
+469.64%
Ms. Lori J. Ryerkerk
Ms. Lori J. Ryerkerk
Independent Director
Independent Director
516.00
--
Ms. Lauren M. Tyler
Ms. Lauren M. Tyler
Independent Director
Independent Director
--
--
Mr. Bennett S. Murphy
Mr. Bennett S. Murphy
Senior Vice President, Investor Relations
Senior Vice President, Investor Relations
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Ms. Elizabeth S. Campbell
Ms. Elizabeth S. Campbell
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
27.24K
+112.43%
Ms. Silvana Battaglia
Ms. Silvana Battaglia
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
20.47K
+80.39%
Mr. Lon R. Greenberg
Mr. Lon R. Greenberg
Independent Director
Independent Director
19.11K
-13.57%
Mr. Dennis M. Nally
Mr. Dennis M. Nally
Independent Director
Independent Director
12.63K
+0.83%
Mr. Pawan Verma
Mr. Pawan Verma
Executive Vice President, Chief Data and Information Officer
Executive Vice President, Chief Data and Information Officer
5.15K
+23.04%
Mr. Werner Baumann
Mr. Werner Baumann
Independent Director
Independent Director
3.13K
+3.57%
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
12.02%
BlackRock Institutional Trust Company, N.A.
6.60%
State Street Investment Management (US)
4.74%
Walgreens Boots Alliance Inc
3.85%
T. Rowe Price Associates, Inc.
3.79%
Other
69.00%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
12.02%
BlackRock Institutional Trust Company, N.A.
6.60%
State Street Investment Management (US)
4.74%
Walgreens Boots Alliance Inc
3.85%
T. Rowe Price Associates, Inc.
3.79%
Other
69.00%
Shareholder Types
Shareholders
Proportion
Investment Advisor
53.44%
Investment Advisor/Hedge Fund
30.19%
Corporation
3.85%
Research Firm
3.09%
Hedge Fund
2.83%
Pension Fund
2.43%
Bank and Trust
2.23%
Sovereign Wealth Fund
1.26%
Family Office
1.17%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
2325
185.17M
94.90%
+31.68K
2025Q3
2360
185.31M
95.09%
+4.64M
2025Q2
2343
180.65M
95.85%
-533.00K
2025Q1
2278
180.99M
94.03%
-1.15M
2024Q4
2205
177.00M
96.12%
-3.08M
2024Q3
2114
179.91M
93.30%
+3.58M
2024Q2
2070
176.04M
91.35%
-1.09M
2024Q1
2048
176.18M
88.49%
-350.13K
2023Q4
1964
171.90M
85.06%
+6.01M
2023Q3
1864
166.03M
82.05%
+4.34M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
22.40M
11.55%
+1.12M
+5.26%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
12.03M
6.21%
+1.02M
+9.29%
Jun 30, 2025
State Street Investment Management (US)
8.41M
4.34%
-6.73K
-0.08%
Jun 30, 2025
Walgreens Boots Alliance Inc
7.47M
3.85%
-2.91M
-28.01%
Jun 30, 2025
T. Rowe Price Associates, Inc.
7.46M
3.85%
-1.87M
-20.05%
Jun 30, 2025
Geode Capital Management, L.L.C.
4.79M
2.47%
+284.23K
+6.31%
Jun 30, 2025
Boston Partners
4.42M
2.28%
-991.53K
-18.32%
Jun 30, 2025
Wellington Management Company, LLP
3.86M
1.99%
-1.57M
-28.88%
Jun 30, 2025
JP Morgan Asset Management
2.76M
1.43%
-110.19K
-3.83%
Jun 30, 2025
Fidelity Management & Research Company LLC
2.78M
1.44%
+751.58K
+36.98%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
VanEck Pharmaceutical ETF
8.42%
AdvisorShares Focused Equity ETF
5.56%
First Trust Consumer Staples Alphadex Fund
3.52%
Goldman Sachs Future Health Care Equity ETF
3.48%
VanEck Retail ETF
3.31%
Hennessy Sustainable ETF
3.08%
iShares US Consumer Staples ETF
3.02%
American Century Mid Cap Growth Impact ETF
2.66%
SEI Enhanced US Large Cap Momentum Factor ETF
2.51%
Counterpoint Quantitative Equity ETF
2.4%
View more
VanEck Pharmaceutical ETF
Proportion8.42%
AdvisorShares Focused Equity ETF
Proportion5.56%
First Trust Consumer Staples Alphadex Fund
Proportion3.52%
Goldman Sachs Future Health Care Equity ETF
Proportion3.48%
VanEck Retail ETF
Proportion3.31%
Hennessy Sustainable ETF
Proportion3.08%
iShares US Consumer Staples ETF
Proportion3.02%
American Century Mid Cap Growth Impact ETF
Proportion2.66%
SEI Enhanced US Large Cap Momentum Factor ETF
Proportion2.51%
Counterpoint Quantitative Equity ETF
Proportion2.4%
Dividend
A total of
2.01B
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Nov 04, 2025
COR.NB Final Cash Dividend of gross USD 0.6 paid on Dec 01, 2025 going ex on Nov 14, 2025
Nov 14, 2025
Dec 01, 2025
Nov 14, 2025
Aug 06, 2025
COR.NB Interim Cash Dividend of gross USD 0.55 paid on Sep 03, 2025 going ex on Aug 15, 2025
Aug 15, 2025
Sep 03, 2025
Aug 15, 2025
May 07, 2025
COR.NB Interim Cash Dividend of gross USD 0.55 paid on Jun 02, 2025 going ex on May 16, 2025
May 16, 2025
Jun 02, 2025
May 16, 2025
Feb 05, 2025
COR.NB Interim Cash Dividend of gross USD 0.55 paid on Mar 03, 2025 going ex on Feb 14, 2025
Feb 14, 2025
Mar 03, 2025
Feb 14, 2025
Nov 06, 2024
COR.NB Final Cash Dividend of gross USD 0.55 paid on Nov 29, 2024 going ex on Nov 15, 2024
Nov 15, 2024
Nov 29, 2024
Nov 15, 2024
Jul 31, 2024
COR.NB Interim Cash Dividend of gross USD 0.51 paid on Aug 26, 2024 going ex on Aug 09, 2024
Aug 09, 2024
Aug 26, 2024
Aug 09, 2024
May 01, 2024
COR.NB Interim Cash Dividend of gross USD 0.51 paid on May 24, 2024 going ex on May 09, 2024
May 10, 2024
May 24, 2024
May 09, 2024
Jan 31, 2024
COR.NB Interim Cash Dividend of gross USD 0.51 paid on Feb 26, 2024 going ex on Feb 08, 2024
Feb 09, 2024
Feb 26, 2024
Feb 08, 2024
Nov 02, 2023
COR.NB Final Cash Dividend of gross USD 0.51 paid on Nov 27, 2023 going ex on Nov 10, 2023
Nov 13, 2023
Nov 27, 2023
Nov 10, 2023
Aug 02, 2023
COR.NB Interim Cash Dividend of gross USD 0.485 paid on Aug 28, 2023 going ex on Aug 10, 2023
Aug 11, 2023
Aug 28, 2023
Aug 10, 2023
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Cencora Inc?
The top five shareholders of Cencora Inc are:
The Vanguard Group, Inc. holds 22.40M shares, accounting for 11.55% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 12.03M shares, accounting for 6.21% of the total shares.
State Street Investment Management (US) holds 8.41M shares, accounting for 4.34% of the total shares.
Walgreens Boots Alliance Inc holds 7.47M shares, accounting for 3.85% of the total shares.
T. Rowe Price Associates, Inc. holds 7.46M shares, accounting for 3.85% of the total shares.
The Vanguard Group, Inc. holds 22.40M shares, accounting for 11.55% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 12.03M shares, accounting for 6.21% of the total shares.
State Street Investment Management (US) holds 8.41M shares, accounting for 4.34% of the total shares.
Walgreens Boots Alliance Inc holds 7.47M shares, accounting for 3.85% of the total shares.
T. Rowe Price Associates, Inc. holds 7.46M shares, accounting for 3.85% of the total shares.
What are the top three shareholder types of Cencora Inc?
The top three shareholder types of Cencora Inc are:
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
How many institutions hold shares of Cencora Inc (COR)?
As of 2025Q4, 2325 institutions hold shares of Cencora Inc, with a combined market value of approximately 185.17M, accounting for 94.90% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -0.19%.
What is the biggest source of revenue for Cencora Inc?
In --, the -- business generated the highest revenue for Cencora Inc, amounting to -- and accounting for --% of total revenue.
